Related Articles
The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway
Urantide prevents CCl4‑induced acute liver injury in rats by regulating the MAPK signalling pathway
UII/GPR14 is involved in NF-κB-mediated colonic inflammation in vivo and in vitro
Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation